Solasia Pharma K.K.
TSE:4597.T
49 (JPY) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 617 | 1,092 | 559 | 454 | 1,310 | 318 | 410.851 | 501.319 | 229.466 | 11.952 |
| Cost of Revenue
| 780 | 430 | 185 | 209 | 65 | 213 | 0.527 | 0.882 | 0 | 0 |
| Gross Profit
| -163 | 662 | 374 | 245 | 1,245 | 105 | 410.324 | 500.437 | 229.466 | 11.952 |
| Gross Profit Ratio
| -0.264 | 0.606 | 0.669 | 0.54 | 0.95 | 0.33 | 0.999 | 0.998 | 1 | 1 |
| Reseach & Development Expenses
| 403 | 883 | 845 | 1,928 | 1,138 | 1,463 | 773.518 | 475.419 | 473.007 | 237.207 |
| General & Administrative Expenses
| 1,073 | 2,250 | 1,948 | 2,432 | 1,868 | 1,061 | 647.015 | 488.377 | 458.881 | 476.756 |
| Selling & Marketing Expenses
| -500 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 573 | 2,250 | 1,948 | 2,432 | 1,868 | 1,061 | 647.015 | 488.377 | 458.881 | 476.756 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.006 |
| Operating Expenses
| 976 | 3,133 | 2,793 | 4,360 | 3,006 | 2,524 | 1,420.533 | 963.796 | 931.888 | 713.963 |
| Operating Income
| -1,139 | -2,471 | -2,419 | -4,116 | -1,762 | -2,420 | -1,009.681 | -462.477 | -702.422 | -702.011 |
| Operating Income Ratio
| -1.846 | -2.263 | -4.327 | -9.066 | -1.345 | -7.61 | -2.458 | -0.923 | -3.061 | -58.736 |
| Total Other Income Expenses Net
| 9 | -21 | -23 | -43 | -35 | -25 | -6.603 | -32.162 | -8.335 | 0.029 |
| Income Before Tax
| -1,130 | -2,492 | -2,442 | -4,159 | -1,797 | -2,445 | -1,016.285 | -494.639 | -710.757 | -701.982 |
| Income Before Tax Ratio
| -1.831 | -2.282 | -4.369 | -9.161 | -1.372 | -7.689 | -2.474 | -0.987 | -3.097 | -58.733 |
| Income Tax Expense
| -22 | 56 | 35 | -32 | 70 | -23 | -8.803 | -20.203 | -66.869 | -24.946 |
| Net Income
| -1,112 | -2,548 | -2,477 | -4,127 | -1,867 | -2,422 | -1,007.481 | -474.436 | -643.887 | -677.035 |
| Net Income Ratio
| -1.802 | -2.333 | -4.431 | -9.09 | -1.425 | -7.616 | -2.452 | -0.946 | -2.806 | -56.646 |
| EPS
| -6.61 | -16.76 | -19.03 | -35.16 | -17.75 | -25.98 | -12.24 | -11.5 | -17.44 | -16.4 |
| EPS Diluted
| -6.61 | -16.76 | -19.03 | -35.16 | -17.75 | -25.98 | -12.24 | -11.49 | -17.43 | -8.06 |
| EBITDA
| -639 | -1,940 | -1,924 | -3,620 | -1,287 | -2,267 | -1,008.976 | -460.749 | -701.319 | -701.484 |
| EBITDA Ratio
| -1.036 | -1.777 | -3.442 | -7.974 | -0.982 | -7.129 | -2.456 | -0.919 | -3.056 | -58.692 |